Please ensure Javascript is enabled for purposes of website accessibility

CU Anschutz study shows dopamine acts with precision

ColoradoBiz Staff //July 18, 2025//

Deposit Photos.

Deposit Photos.

CU Anschutz study shows dopamine acts with precision

ColoradoBiz Staff //July 18, 2025//

Listen to this article

AURORA, Colo — A new study from the University of Colorado Anschutz Medical Campus has overturned decades of neuroscience theory, revealing that dopamine signals in the brain with far more precision than previously believed. The findings, published Thursday in Science, could open the door to more targeted treatments for disorders such as Parkinson’s disease, schizophrenia and addiction.

In Brief:
  • study shows dopamine works in precise bursts
  • Findings challenge decades-old neuroscience theories
  • Localized dopamine signals impact learning and movement
  • Potential to improve treatment for Parkinson’s and addiction

For years, scientists believed dopamine functioned as a broad chemical broadcaster, influencing large areas of the brain at once. But the research team, led by , a professor at the University of Colorado School of Medicine, discovered that dopamine instead communicates in highly localized, specific patterns — more like a postal service delivering messages to exact neural addresses.

“Our current research found that and transmission in the brain is much more complex than we thought,” Ford said. “Our work gives the beginning of a framework for understanding how all those different behaviors could all be regulated by dopamine.”

Using advanced microscopy techniques, the researchers observed that dopamine is released in small, concentrated bursts, or “hotspots,” which affect nearby cells rapidly. These localized signals work alongside broader signals that trigger slower, more general effects across the brain. The combination allows dopamine to fine-tune neural circuits while also coordinating large-scale brain functions such as movement, learning and decision-making.

The findings carry major implications for treating dopamine-related conditions. Current therapies often aim to increase or stabilize overall dopamine levels. But this study suggests that restoring the precision of dopamine delivery may be just as critical to improving outcomes.

“We are only at the tip of the iceberg in trying to understand how dysfunctions in dopamine contribute to diseases like Parkinson’s, schizophrenia or addiction,” Ford said. “The goal would be to build on these findings to come up with new and improved treatments.”

o